Literature DB >> 22045668

Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development.

Anna Alisi, Rita Carsetti, Valerio Nobili.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22045668     DOI： 10.1002/hep.24611

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  19 in total

1.  Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease.

Authors:  Manoj Kumar Pandey; Reena Rani; Wujuan Zhang; Kenneth Setchell; Gregory A Grabowski
Journal:  Mol Genet Metab       Date:  2012-04-30       Impact factor: 4.797

Review 2.  Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes.

Authors:  Zhiguo Xie; Gan Huang; Zhen Wang; Shuoming Luo; Peilin Zheng; Zhiguang Zhou
Journal:  J Mol Med (Berl)       Date:  2018-07-12       Impact factor: 4.599

Review 3.  Vitamin D: a new player in non-alcoholic fatty liver disease?

Authors:  Myrto Eliades; Elias Spyrou
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

Review 4.  Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.

Authors:  Sara Ceccarelli; Valerio Nobili; Anna Alisi
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 5.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 6.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

7.  Emodin prevents intrahepatic fat accumulation, inflammation and redox status imbalance during diet-induced hepatosteatosis in rats.

Authors:  Anna Alisi; Anna Pastore; Sara Ceccarelli; Nadia Panera; Daniela Gnani; Giovannella Bruscalupi; Mara Massimi; Giulia Tozzi; Fiorella Piemonte; Valerio Nobili
Journal:  Int J Mol Sci       Date:  2012-02-20       Impact factor: 6.208

8.  NADPH Oxidase Inhibition in Fibrotic Pathologies.

Authors:  Karen Bernard; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2020-03-04       Impact factor: 7.468

9.  Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis.

Authors:  Anna Alisi; Sara Ceccarelli; Nadia Panera; Valerio Nobili
Journal:  Front Cell Infect Microbiol       Date:  2012-10-26       Impact factor: 5.293

Review 10.  Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.

Authors:  Valentina Giorgio; Federica Prono; Francesca Graziano; Valerio Nobili
Journal:  BMC Pediatr       Date:  2013-03-25       Impact factor: 2.125
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.